Literature DB >> 12378534

RNA is more sensitive than DNA in identification of breast cancer patients bearing tumor nucleic acids in plasma.

Javier Silva, Jose M Silva, Vanesa García, Jose M García, Gemma Domínguez, Félix Bonilla.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12378534     DOI： 10.1002/gcc.10124

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN： 1045-2257            Impact factor:   5.006


× No keyword cloud information.
  4 in total

1.  EPAS1 mRNA in plasma from colorectal cancer patients is associated with poor outcome in advanced stages.

Authors:  N Mohammed; M Rodriguez; V Garcia; J M Garcia; G Dominguez; C Peña; M Herrera; I Gomez; R Diaz; B Soldevilla; A Herrera; J Silva; F Bonilla
Journal:  Oncol Lett       Date:  2011-04-28       Impact factor: 2.967

Review 2.  Circulating RNAs as new biomarkers for detecting pancreatic cancer.

Authors:  Takahiro Kishikawa; Motoyuki Otsuka; Motoko Ohno; Takeshi Yoshikawa; Akemi Takata; Kazuhiko Koike
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

3.  Serum messenger RNA as a biomarker and its clinical usefulness in malignancies.

Authors:  Norimasa Miura; Junichi Hasegawa; Goshi Shiota
Journal:  Clin Med Oncol       Date:  2008-09-22

4.  Circulating Bmi-1 mRNA as a possible prognostic factor for advanced breast cancer patients.

Authors:  Javier Silva; Vanesa García; José M García; Cristina Peña; Gemma Domínguez; Raquel Díaz; Yolanda Lorenzo; Alicia Hurtado; Antonio Sánchez; Félix Bonilla
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.